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Strengths and limitations of this study
 ► Primary care physicians were recruited from 20 
European countries.
 ► A convenience sample chosen by national leads was 
used, which may not be representative of their na-
tions as a whole.
 ► This study examines secondary data; the survey 
questions were not specifically designed for this 
analysis.
AbStrACt
Objective The overall objective of this study was to 
examine the differences in ultrasound availability in 
primary care across Europe.
Design Cross-sectional study.
Setting Primary care.
Participants Primary care physicians (PCPs).
Primary and secondary outcomes measures The 
primary aim was to describe the variation in in-house 
primary care ultrasonography availability across 
Europe using descriptive statistics. The secondary 
aim was to explore associations between in-house 
ultrasonography availability and the characteristics of 
PCPs and their clinics using a mixed-effects logistic 
regression model.
results We collected data from 20 European countries. 
A total of 2086 PCPs participated, varying from 59 to 
446 PCPs per country. The median response rate per 
country was 24.8%. The median (minimum–maximum) 
percentage of PCPs across Europe with access to 
in-house abdominal ultrasonography was 15.3% 
(0.0%–98.1%) and 12.1% (0.0%–30.8%) had access 
to in-house pelvic ultrasonography with large variations 
between countries. We found associations between 
in-house abdominal ultrasonography availability and 
larger clinics (OR 2.5, 95% CI 1.2 to 4.9) and clinics 
with medical doctors specialised in areas, which 
traditionally use ultrasonography (OR 2.1, 95% CI 1.1 to 
3.8). Corresponding associations were found between 
in-house pelvic ultrasonography availability and larger 
clinics (OR 1.9, 95% CI 1.3 to 2.7) and clinics with 
medical doctors specialised in areas, which traditionally 
use ultrasonography (OR 3.0, 95% CI 1.8 to 5.1). 
Additionally, we found a negative association between 
urban clinics and in-house pelvic ultrasound availability 
(OR 0.5, 95% CI 0.2 to 0.9).
Conclusions Across Europe, there is a large variation 
in PCPs’ access to in-house ultrasonography and 
organisational aspects of primary care seem to 
determine this variation. If evidence continues to support 
ultrasonography as a front-line point-of-care test, 
implementation strategies for increasing its availability 
in primary care are needed. Future research should 
focus on facilitators and barriers that may affect the 
implementation process.
IntrODuCtIOn
Traditionally, ultrasound examinations were 
performed primarily by trained radiologists 
using high-end devices. However, the devel-
opment in technology has made ultrasound 
devices smaller, better and cheaper, and 
thereby more accessible to clinicians.1 2 Today, 
diagnostic ultrasonography is performed 
either by an imaging specialist for a full 
comprehensive description of organ anatomy 
and pathology, or as a bedside point-of-care 
test where the clinician uses it in relation to 
the physical examination to rule in or rule 
out specific conditions.1 3 Indeed, ultrasound 
examinations are increasingly used in both 
primary and secondary care to improve diag-
nosis and facilitate patient pathways.4–6
Whereas the use of ultrasonography in 
secondary care is well described,1 4 7 literature 
on its use in primary care is sparse.5 6 8 Studies 
have suggested that point-of-care ultrasonog-
raphy performed by primary care physicians 
(PCPs) may lead to improved diagnostic accu-
racy.5 9 However, ultrasonography is an oper-
ator-dependent examination and sufficient 
training of PCPs performing ultrasonography 
is paramount, especially if the frequency of 
performed ultrasound examinations is low. 
Today, ultrasound examinations in primary 
care may be performed by both specialists10 
and general practitioners (GPs),11 depending 
on how the healthcare systems across Europe 
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are organised.12 13 GPs with access to diagnostic tests have 
been found to diagnose, treat and refer patients more 
appropriately.14 Hence, in-house availability of ultraso-
nography in primary care may improve patient care.
The availability and use of ultrasound examinations 
in primary care differs between countries: experts have 
previously estimated that the proportion of primary care 
users across Europe varies from less than 1% to 67%,15 
and in-house availability of ultrasonography varies from 
4% to 58% in the Nordic countries alone.16 We do not 
know what determines this variation or the extent to 
which PCP and clinic characteristics are associated with 
the likelihood of in-house availability of ultrasonography.
The aims of this study were to describe the variation in 
in-house primary care ultrasonography availability across 
Europe, and the association between this availability and 
the characteristics of PCPs and their clinics.
MAterIAlS AnD MethODS
Our study was a secondary analysis of data from the 
Örenäs survey.17 The Örenäs survey investigated the 
influence of health system factors on the way that Euro-
pean PCPs manage their patients. As well as collection of 
demographic data, there was collection of data on PCPs’ 
in-house access to diagnostic abdominal and pelvic ultra-
sonography. In the present study, this access is compared 
with the demographic data. A predefined protocol was 
developed prior to accessing the data (see online supple-
mentary file 1).
The questionnaire was piloted twice by PCPs in 16 
Örenäs Research Group centres. Translations of the ques-
tionnaire into local languages were made where these 
languages were not English. Translation was validated by 
back-translation to assess semantic and conceptual equiv-
alence and is described elsewhere.18 The questionnaires 
were put online using SurveyMonkey (SurveyMonkey, 
California, USA).
Participants and recruitment
The study was conducted in 25 Örenäs Research Group 
centres in 20 countries across Europe. In some coun-
tries, more than one Örenäs Research Group was keen to 
collect data for this study. In those countries, each group 
recruited participants on a regional basis, so there was no 
risk of geographical overlap.
Subjects were eligible for the survey if they were GPs or 
had specialist training, but worked in the community and 
could be accessed directly by patients without referral.
Each Örenäs Research Group local lead emailed a 
survey invitation to the PCPs in their local health district, 
with the aim of recruiting at least 50 participants. The 
Örenäs Research Group local leads were asked to recruit 
a varied sample with regards to gender, years since grad-
uation, site of practice (urban, rural, remote) and size of 
practice. Consent was implied by agreeing to take part in 
the survey.
Data collection
Access to ultrasonography
Participants were asked if abdominal or pelvic diagnostic 
ultrasonography was available to them in (1) their own 
practice, (2) at their request outside their practice, or 
(3) not directly available to them, or only available via a 
specialist. We divided this into Access to in-house abdominal 
ultrasonography (AbdUS) and No access to in-house AbdUS 
(including access at their request outside their prac-
tices, not directly available to them or only available via 
a specialist) and correspondingly: Access to in-house pelvic 
ultrasonography (PelUS) and No access to in-house PelUS. 
Hence, the variables In-house access to AbdUS and In-house 
access to PelUS included direct access to diagnostic ultraso-
nography in respondents’ own practices.
Countries included
The survey was circulated in 20 countries across Europe: 
Bulgaria, Croatia, Denmark, England, Finland, France, 
Germany (Essen and Munich), Greece, Israel, Italy, 
Netherlands, Norway, Poland (Bydgoszcz and Białystok), 
Portugal, Romania, Scotland, Slovenia, Spain (Barcelona, 
Galicia and Mallorca), Sweden and Switzerland.
Characteristics of the PCPs
PCPs were characterised by Gender, male/female; Level 
of seniority, <10 years of experience as a medical doctor 
and ≥10 years (including 10–19, 20–29, 30–39, 40 years 
or over); and Specialty of the PCP, GP/not GP (including 
specialists in ear, nose and throat, internal/general medi-
cine, obstetrics/gynaecology, oncology, orthopaedics, 
paediatrics, other).
Characteristics of the clinics
PCPs’ clinics were characterised by location (self-defined by 
participants): urban or non-urban (including rural, island, 
mixed), and clinic size (number of PCPs in the clinic: solo (1 
PCP), small (2–5 PCPs), medium (6–9 PCPs) and large 
(10 or more PCPs)).
In the survey, participants were asked if they had 
colleagues qualified in different specialties (ear, nose 
and throat, internal/general medicine, obstetrics/gynae-
cology, oncology, orthopaedics, paediatrics or other). We 
assessed the proportion of PCPs with colleagues in their 
clinic who were qualified in a specialty in which ultrasonog-
raphy is traditionally used (where clinical guidelines for 
use and educational programmes exist for the specialty). 
We estimated this as the Proportion of PCPs having specialist 
in internal medicine in their clinic and the Proportion of PCPs 
with an obstetrician/gynaecologist colleague in their own clinic. 
Finally, we noted any free-text comments that the PCPs 
had a Sonographer/radiologist colleague in the clinic, elabo-
rated under the reply ‘other’. Free text comments were 
translated using Google Translate.
ethics
Other countries’ study leads either achieved local ethical 
approval or gave statements that formal ethical approval 
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was not needed in their jurisdictions (see online supple-
mentary file 2).
Patient and public involvement
Patients were not involved in this study.
Statistics
We calculated the proportions of PCPs with in-house 
access to AbdUS or PelUS for each of the characteris-
tics. A mixed-effects logistic regression model was used 
to test associations between access to in-house ultraso-
nography and the characteristics of the PCP and clinic. 
To avoid estimating a large number of parameters, the 
mixed-effects logistic regression model included fixed 
effects for all variables and random effects for variables 
dependent on country. This model allowed us to look 
across countries and captured the country effect without 
losing too many degrees of freedom. To identify vari-
ables dependent on country, we used multiple logistic 
regression including main effects and interactions with 
country between each of the other main-effects variables. 
Backwards model selection was used to eliminate insig-
nificant terms from the model. Missing data were consid-
ered completely random and ignored in the analysis. The 
model was estimated in STATA V.15.0 (StataCorp, College 
Station, Texas, USA). Statistical significance was defined 
as a p value ≤0.05.
results
A total of 2086 PCPs participated, varying from 59 to 
446 PCPs per country. The median response rate per 
country was 24.8% (range, 7.1%–65.6%). There was a 
large between-country variation in the variables: 61.7% 
(range, 17.2%–88.0%) were female and 38.3% (range, 
12.0%–82.8%) male; 96.9% (range, 81.6%–100%) were 
specialised as GPs, and 16.0% (range, 1.6%–55.9%) had 
less than 10 years’ experience as a medical doctor. The 
clinics were mainly urban: 59.7% (range, 28.6%–93.1%); 
13.8% (range, 0.0%–55.2%) were solo practices, 39.0% 
(range, 7.9%–67.9%) small, 20.9% (range, 3.2%–55.5%) 
medium and 26.2% (range, 0.0%–70.1%) large. Between-
country variations are shown in table 1.
Using multiple logistic regression, we identified inter-
actions between country and variables describing the 
characteristics of the clinics (Location, Clinic size, In-house 
colleague qualified in a medical specialty which traditionally 
uses ultrasonography). There were no interactions between 
country and variables describing the characteristics of the 
PCP (Gender, Level of seniority, Specialty of the PCP). 
As a result, we applied a mixed-effects logistic regression 
model that included fixed effects for all variables and 
random effects for variables describing the characteristics 
of the clinics. Visual inspection of the country-specific 
random effects showed concordance between AbdUS 
and PelUS, indicating comparable parameter estimates 
and that the country effects were modelled appropriately. 
Hence, we applied the same model structure to both 
AbdUS and PelUS.
Twenty-one observations from nine different countries 
were excluded due to an unreported number of PCPs 
working in the clinic. We chose to consider these missing 
data random, as we believed that the likelihood of the 
PCP answering the question about the number of PCPs 
working in the clinic was independent from the PCP’s 
access to in-house AbdUS or PelUS.
Variation in access to in-house ultrasonography between countries 
and between regions within a country
The median percentage of PCPs across Europe with access 
to in-house AbdUS was 15.3% (range, 0.0%–98.1%) 
and 12.1% (range, 0.0%–30.8%) had access to in-house 
PelUS. However, there was large variation between coun-
tries (table 1 and figure 1).
In-house access to AbdUS was very common in 
Germany (98.0%), followed by Slovenia (41.4%) and 
Switzerland (40.6%). In-house access to AbdUS was least 
available in England (0%), Croatia (1.5%) and Denmark 
(1.9%). Compared with AbdUS, in-house access to PelUS 
was less common, with the highest proportions found in 
Finland (30.8%), Slovenia (21.5%) and France (20.3%). 
In contrast, it was uncommon in England (0%), Croatia 
(1.5%) and Bulgaria (3.4%).
In addition, there were large differences in access to 
in-house AbdUS between the two Polish regions (Bialy-
stok 17.9 and Bydgoszcz 57.9%) and the three Spanish 
regions (Mallorca 3.8%, Galicia 9.6% and Barcelona 
43.7%), whereas there was little difference between the 
two German regions (Munich 96.3% and Essen 98.7%). 
There was also a large variation in the proportions of 
clinics with access to in-house PelUS in Germany (Essen 
1.3% and Munich 11.1%), Poland (Bialystok 8.4% and 
Bydgoszcz 33.3%) and Spain (Galicia 4.8%, Mallorca 
6.0% and Barcelona 25.8%).
PCP characteristics and in-house access to ultrasonography
We found no statistically significant associations between 
the PCP characteristics and in-house access to AbdUS or 
PelUS (table 2).
Clinic characteristics and in-house access to ultrasonography
Larger practices were significantly associated with higher 
levels of both in-house access to AbdUS (OR 2.5, 95% CI 
1.2 to 4.9) and PelUS (OR 1.9, 95% CI 1.3 to 2.7), while 
we found a negative association between a small practice 
size and PelUS (OR 0.6, 95% CI 0.4 to 0.9) compared 
with solo practices. We also found a negative associa-
tion between urban location and with higher levels of 
PelUS (OR 0.5, 95% CI 0.2 to 0.9). Having an in-house 
colleague specialised in a medical field which tradition-
ally uses ultrasonography was found to be positively asso-
ciated with having access to in-house AbdUS (OR 2.1, 
95% CI 1.1 to 3.8) and PelUS (OR 3.0, 95% CI 1.8 to 
5.1); 36.1% of PCPs with in-house AbdUS had an internal 
medicine colleague in their clinics, and 29.7% of PCPs 
 on O
ctober 29, 2019 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-030958 on 30 S
eptem
ber 2019. D
ow
nloaded from
 
4 Aakjær Andersen C, et al. BMJ Open 2019;9:e030958. doi:10.1136/bmjopen-2019-030958
Open access 
Ta
b
le
 1
 
D
es
cr
ip
tio
n 
of
 p
ar
tic
ip
at
in
g 
P
C
P
s 
an
d
 t
he
ir 
p
ra
ct
ic
es
C
o
un
tr
y
n (%
)
P
C
P
 c
ha
ra
ct
er
is
ti
cs
 n
 (%
)
C
lin
ic
 c
ha
ra
ct
er
is
ti
cs
 n
 (%
)
A
cc
es
s 
A
b
d
U
S
A
cc
es
s 
P
el
U
S
G
en
d
er
S
en
io
ri
ty
S
p
ec
ia
lis
at
io
n
Lo
ca
ti
o
n
C
lin
ic
 s
iz
e
Fe
m
al
e
M
al
e
<
10
 
ye
ar
s
≥1
0 
ye
ar
s
G
P
N
o
t 
G
P
U
rb
an
N
o
t 
ur
b
an
S
o
lo
S
m
al
l
M
ed
iu
m
La
rg
e
n 
(%
)
n 
(%
)
B
ul
ga
ria
59 (6
5.
6)
44 (7
7.
2)
13 (2
2.
8)
8 (1
3.
8)
50 (8
6.
2)
52 (9
6.
3)
2 (3
.7
)
44 (7
5.
9)
14 (2
4.
1)
32 (5
5.
2)
17 (2
9.
3)
2 (3
.5
)
7 (1
2.
1)
8 (1
3.
6)
2 (3
.4
)
C
ro
at
ia
67 (2
2.
9)
54 (8
1.
8)
12 (1
8.
2)
11 (1
6.
9)
54 (8
3.
1)
52 (9
6.
3)
2 (3
.7
)
31 (4
6.
3)
36 (5
3.
7)
33 (4
9.
3)
21 (3
1.
3)
11 (1
6.
4)
2 (3
.0
)
1 (1
.5
)
1 (1
.5
)
D
en
m
ar
k
10
7
(2
6.
8)
59 (5
7.
8)
43 (4
2.
2)
6 (5
.9
)
96 (9
4.
1)
85 (1
00
.0
)
0 (0
.0
)
68 (6
6.
7)
34 (3
3.
3)
18 (1
7.
6)
62 (6
0.
8)
19 (1
8.
6)
3 (2
.9
)
2 (1
.9
)
4 (3
.4
)
E
ng
la
nd
65 (2
1.
7)
46 (7
0.
8)
19 (2
9.
2)
12 (1
8.
8)
52 (8
1.
3)
65 (1
00
.0
)
0 (0
.0
)
28 (4
3.
1)
37 (5
6.
9)
0 (0
.0
)
19 (2
9.
2)
35 (5
3.
9)
11 (1
6.
9)
0 (0
.0
)
0 (0
.0
)
Fi
nl
an
d
65 (3
6.
5)
45 (6
9.
2)
20 (3
0.
8)
29 (4
4.
6)
36 (5
5.
4)
51 (9
8.
1)
1 (1
.9
)
56 (8
6.
2)
9 (1
3.
9)
2 (3
.2
)
5 (7
.9
)
21 (3
3.
3)
35 (5
5.
6)
23 (3
5.
38
)
20 (3
0.
77
)
Fr
an
ce
59 (1
0.
7)
32 (5
4.
2)
27 (4
5.
8)
33 (5
5.
9)
26 (4
4.
1)
59 (1
00
.0
)
0 (0
.0
)
54 (9
3.
1)
4 (6
.9
)
6 (1
0.
2)
36 (6
1.
0)
8 (1
3.
6)
9 (1
5.
3)
9 (1
5.
25
)
12 (2
0.
34
)
G
er
m
an
y
10
3
(4
2.
6)
30 (2
9.
1)
73 (7
0.
9)
3 (2
.9
)
99 (9
7.
1)
84 (8
1.
6)
19 (1
8.
5)
61 (5
9.
2)
42 (4
0.
8)
26 (2
5.
2)
74 (7
1.
8)
3 (2
.9
)
0 (0
.0
)
10
1
(9
8.
06
)
4 (3
.8
8)
G
re
ec
e
68 (2
1.
4)
34 (5
0.
0)
34 (5
0.
0)
0 (0
.0
)
68 (1
00
)
67 (9
8.
5)
1 (1
.5
)
20 (2
9.
4)
48 (7
06
)
24 (3
6.
4)
22 (3
3.
3)
7 (1
0.
6)
13 (1
9.
7)
11 (1
6.
18
)
9 (1
3.
24
)
Is
ra
el
75 (2
2.
1)
38 (5
0.
7)
37 (4
9.
3)
17 (2
3.
0)
57 (7
7.
0)
71 (9
7.
3)
2 (2
.7
)
66 (8
8.
0)
9 (1
2.
0)
7 (9
.3
)
43 (5
7.
3)
18 (2
4.
0)
7 (9
.3
)
6 (8
.0
)
9 (1
2.
0)
Ita
ly
63 (3
1.
5)
20 (3
3.
3)
40 (6
6.
7)
4 (6
.5
)
58 (9
3.
5)
36 (8
3.
7)
7 (1
6.
3)
31 (4
9.
2)
32 (5
0.
8)
22 (3
4.
9)
22 (3
4.
9)
10 (1
5.
8)
9 (1
4.
3)
12 (1
9.
05
)
8 (1
2.
7)
N
et
he
rla
nd
s
11
3
(7
.1
)
51 (4
6.
4)
59 (5
3.
6)
17 (1
5.
3)
94 (8
4.
7)
32 (9
1.
4)
3 (8
.6
)
55 (4
9.
1)
57 (5
0.
9)
5 (4
.5
)
76 (6
7.
9)
29 (2
5.
9)
2 (1
.8
)
13 (1
1.
5)
10 (8
.8
5)
N
or
w
ay
90 (1
8.
0)
40 (4
4.
4)
50 (5
5.
6)
20 (2
2.
2)
70 (7
7.
8)
73 (1
00
.0
)
0 (0
.0
)
50 (5
5.
6)
40 (4
4.
4)
3 (3
.3
)
58 (6
4.
4)
26 (2
8.
9)
3 (3
.3
)
12 (1
3.
33
)
11 (1
2.
22
)
P
ol
an
d
15
2
(3
6.
0)
11
0
(7
3.
3)
40 (2
6.
7)
52 (3
4.
4)
99 (6
5.
6)
14
5
(9
6.
0)
6 (4
.0
)
10
8
(7
1.
1)
44 (2
9.
0)
9 (5
.9
)
84 (5
5.
3)
41 (2
7.
0)
18 (1
1.
8)
50 (3
2.
89
)
27 (1
7.
76
)
P
or
tu
ga
l
65 (2
8.
6)
48 (7
3.
9)
17 (2
6.
2)
39 (6
0)
26 (4
0)
65 (1
00
.0
)
0 (0
.0
)
44 (6
7.
7)
21 (3
2.
3)
2 (3
.1
)
14 (2
1.
5)
36 (5
5.
4)
13 (2
0.
0)
2 (3
.0
8)
2 (3
.0
8)
R
om
an
ia
17
7
(–
)
15
4
(8
8.
0)
21 (1
2.
0)
8 (4
.6
)
16
7
(9
5.
4)
17
4
(9
8.
9)
2 (1
.1
)
10
8
(6
1.
7)
67 (3
8.
3)
64 (3
7.
7)
70 (4
1.
2)
14 (8
.2
)
22 (1
2.
9)
56 (3
1.
64
)
38 (2
1.
47
)
S
co
tla
nd
65 (1
8.
6)
31 (4
7.
7)
34 (5
2.
3)
5 (7
.8
)
59 (9
2.
2)
63 (9
8.
4)
1 (1
.6
)
21 (3
2.
3)
44 (6
7.
7)
0 (0
.0
)
18 (2
7.
7)
18 (2
7.
7)
29 (4
4.
6)
10 (1
5.
38
)
10 (1
5.
38
)
S
lo
ve
ni
a
10
4
(2
9.
5)
78 (7
5.
7)
25 (2
4.
3)
17 (1
6.
4)
87 (8
3.
7)
10
2
(9
9.
0)
1 (1
.0
)
44 (4
2.
3)
60 (5
7.
7)
7 (6
.7
)
34 (3
2.
7)
27 (2
6.
0)
36 (3
4.
6)
43 (4
1.
35
)
31 (2
9.
81
)
C
on
tin
ue
d
 on O
ctober 29, 2019 by guest. P
rotected by copyright.
http://bm
jopen.bm
j.com
/
B
M
J O
pen: first published as 10.1136/bm
jopen-2019-030958 on 30 S
eptem
ber 2019. D
ow
nloaded from
 
5Aakjær Andersen C, et al. BMJ Open 2019;9:e030958. doi:10.1136/bmjopen-2019-030958
Open access
C
o
un
tr
y
n (%
)
P
C
P
 c
ha
ra
ct
er
is
ti
cs
 n
 (%
)
C
lin
ic
 c
ha
ra
ct
er
is
ti
cs
 n
 (%
)
A
cc
es
s 
A
b
d
U
S
A
cc
es
s 
P
el
U
S
G
en
d
er
S
en
io
ri
ty
S
p
ec
ia
lis
at
io
n
Lo
ca
ti
o
n
C
lin
ic
 s
iz
e
Fe
m
al
e
M
al
e
<
10
 
ye
ar
s
≥1
0 
ye
ar
s
G
P
N
o
t 
G
P
U
rb
an
N
o
t 
ur
b
an
S
o
lo
S
m
al
l
M
ed
iu
m
La
rg
e
n 
(%
)
n 
(%
)
S
p
ai
n
44
6
(–
)
31
2
(7
0.
4)
13
1
(2
9.
6)
29 (6
.5
)
41
7
(9
3.
5)
43
8
(9
8.
9)
5 (1
.1
)
30
2
(6
7.
9)
14
3
(3
2.
1)
5 (1
.1
)
59 (1
3.
3)
69 (5
5.
5)
31
2
(7
0.
1)
13
3
(2
9.
82
)
81 (1
8.
16
)
S
w
ed
en
79 (1
9.
8)
37 (4
6.
8)
42 (5
3.
2)
20 (2
5.
3)
59 (7
4.
7)
66 (9
5.
7)
3 (4
.4
)
29 (3
6.
7)
50 (6
3.
3)
0 (0
.0
)
34 (4
3.
6)
35 (4
4.
9)
9 (1
1.
5)
3 (3
.8
)
5 (6
.3
3)
S
w
itz
er
la
nd
64 (6
4.
0)
11 (1
7.
2)
53 (8
2.
8)
1 (1
.6
)
63 (9
8.
4)
61 (9
5.
3)
3 (4
.7
)
18 (2
8.
6)
45 (7
1.
4)
21 (3
3.
3)
38 (6
0.
3)
2 (3
.2
)
2 (3
.2
)
26 (4
0.
63
)
7 (1
0.
94
)
To
ta
ls
*
20
86
12
74
79
0
33
1
17
37
18
41
58
12
38
83
6
28
6
80
6
43
1
54
2
52
1
29
1
M
ed
ia
n 
p
er
ce
nt
ag
es
 
(IQ
R
)
56
.0
(4
6.
7–
73
.5
)
44
.0
(2
6.
5–
53
.3
)
15
.9
(6
.4
–
23
.6
)
84
.2
(7
6.
4–
93
.7
)
98
.2
(9
5.
9–
99
.3
)
1.
8
(0
.8
–
4.
1)
57
.4
(4
2.
9–
68
.7
)
42
.6
(3
1.
3–
57
.1
)
8.
0
(3
.2
–
33
.7
)
38
.0
(2
9.
3–
60
.4
)
25
.0
(1
2.
9–
30
.0
)
12
.5
(3
.3
–
19
.8
)
15
.3
(7
.0
–
32
.0
)
12
.1
(3
.8
–
17
.9
)
*A
b
so
lu
te
 n
um
b
er
s 
gi
ve
n 
in
 e
ac
h 
va
ria
b
le
 (n
) d
o 
no
t 
ad
d
 u
p
 t
o 
th
e 
to
ta
l n
um
b
er
 o
f p
ar
tic
ip
an
ts
 in
 e
ac
h 
co
un
tr
y 
(N
) d
ue
 t
o 
m
is
si
ng
 v
al
ue
s.
A
b
d
U
S
, a
b
d
om
in
al
 u
ltr
as
on
og
ra
p
hy
; G
P,
 g
en
er
al
 p
ra
ct
iti
on
er
; N
 (%
), 
nu
m
b
er
 o
f p
ar
tic
ip
an
ts
 in
 e
ac
h 
co
un
ty
 (r
es
p
on
se
 r
at
e)
; n
, a
b
so
lu
te
 v
al
ue
 in
 e
ac
h 
va
ria
b
le
; P
C
P,
 p
rim
ar
y 
ca
re
 p
hy
si
ci
an
; 
P
el
U
S
, p
el
vi
c 
ul
tr
as
on
og
ra
p
hy
.
Ta
b
le
 1
 
C
on
tin
ue
d
having in-house access to PelUS had a specialist in obstet-
rics/gynaecology in their clinics. Nine PCPs (Croatia, 1; 
Finland, 1; Greece, 2; Romania, 1; Scotland, 1; Slovenia, 
3) stated that they had a radiologist or a sonographer in 
their practices.
DISCuSSIOn
Principal findings
We found large variations across Europe in primary care 
access to in-house ultrasonography. The majority of PCPs 
do not have diagnostic ultrasonography available in 
their own clinics. We found some associations between 
characteristics of the clinic and the likelihood of having 
in-house ultrasonography, including a significant associa-
tion between increased likelihood and clinics with more 
than 10 PCPs, and with clinics with colleagues specialised 
in internal medicine or gynaecology/obstetrics. We also 
found an association between increased likelihood of 
having in-house access to PelUS and non-urban clinics. 
Solo clinics were more likely to have in-house PelUS than 
other small clinics.
Strengths and limitations
A strength of this study is the large number of partici-
pating countries, with a response rate higher than 
previous studies.19 20 Moreover, the survey recruitment 
strategy was not biased by access to in-house ultrasonog-
raphy since the overall aim of the survey was to explore 
PCPs’ decision-making with regard to referring patients 
who may have cancer for further investigation.
However, selection bias may have been introduced by 
both the recruitment methods and the survey distribu-
tion, and the participants may not be representative of 
the whole population of PCPs in each country. In most 
of the countries involved, the survey was only circulated 
in one specific region, and in those countries where 
regional data was available, we found inter-regional varia-
tion in ultrasonography access. This means that regional 
differences may have influenced our results.
Using secondary data may introduce information 
bias. In our study, we explored whether having access to 
in-house ultrasonography was associated with having a 
colleague specialised in a medical field that traditionally 
uses ultrasonography. We did not explore whether this 
colleague was actually performing ultrasound examina-
tions in respondents’ clinics. Furthermore, a statement 
that the respondent had a sonographer or radiologist 
colleague in the clinic depended on the participant’s 
free-text answers, and the frequency of this may therefore 
be underestimated.
We collected data on the GPs (gender, level of seniority 
and specialty) and the clinics (location and size); other 
background characteristics may influence the PCP’s 
access to ultrasonography. Thus, residual confounding 
may exist.
This study used an exploratory approach for the 
secondary outcomes and the statistical model included 
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Figure 1 Between-country differences in access to in-house diagnostic ultrasonography.
all possible associations between the measured variables. 
However, the nature of our sample may have caused 
limitations as some associations may have been missed 
due to lack of power, and some variables may have been 
eliminated during the fitting of the model due to lack of 
power. However, the aim of this study was a preliminary 
assessment and more research is needed to determine 
the importance of different factors in relation to in-house 
ultrasonography access.
Comparison with existing literature
In a survey from 2016,15 ultrasound experts estimated the 
proportion of GPs using ultrasonography to vary from 
less than 1% in Austria, Catalonia, Denmark and Sweden 
to 45% in Germany. Our study confirmed significant vari-
ation, although our proportions were higher (figure 1). 
This may be caused by selection bias or by the difference 
between estimations by experts and measured propor-
tions. Furthermore, the previous study estimated PCPs’ 
use of ultrasonography, while our study measured PCPs’ 
actual access to in-house ultrasonography. Access to ultra-
sonography in the Scandinavian countries was explored 
using QUALICOPC data from 2012.16 This found higher 
levels of access than our study (Denmark 11.3%, Finland 
57.7%, Norway 16.7%, Sweden 4.1%). This may be 
because the QUALICOPC study asked about access to any 
type of ultrasound, not specifically diagnostic abdominal 
or pelvic ultrasonography; hence, therapeutic ultrasound 
used for musculoskeletal conditions and A-mode ultra-
sound may have been included in those data.
European between-country variations have also been 
described for other diagnostic tests in primary care13; thus, 
variations in access to in-house ultrasound may be caused 
by national differences in the organisation of primary 
care. For example, the high proportion in Finland may 
be explained by larger healthcare centres with more 
advanced equipment,16 whereas in Germany PCPs are 
taught how to use ultrasonography for abdominal exam-
inations.21 Whether the gate-keeper function that PCPs 
have in some countries,12 the specialty training system for 
PCPs, the PCP’s ultrasound training or the waiting time 
to see a specialist is important is unclear since we did not 
collect data on these issues.
Financial aspects may also be important. In countries 
where PCPs are largely self-employed,22 they need to pay 
for ultrasound equipment themselves. In addition, ultra-
sonography is a time-consuming examination, and differ-
ences in remuneration for performing ultrasonography 
may be of particular importance.12 15 23 Workload for the 
PCP may also be an important factor since research has 
shown considerable variation in the number of consulta-
tions per day23 and the consultation length.24
Distance from the secondary care provider has previ-
ously been found to be of importance for in-house 
PelUS,25–27 and our study also found an association 
between in-house PelUS availability and non-urban prac-
tices. Associations between technology and larger clinics 
have previously been described.23 However, the associa-
tion between larger clinics and access to ultrasonography 
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Table 2 Associations between in-house access to ultrasonography and characteristics of PCPs and clinics
AbdUS
n (%)
OR
(95% CI)* P value†
PelUS
n (%)
OR
(95% CI)* P value†
Characteristics of the PCP
  Male 233 (29.5) 1.1 (1.0 to 1.3) 0.101 116 (14.7) 1.0 (0.9 to 1.2) 0.888
  Female 285 (22.4) – – 175 (13.7) – –
  <10 years of experience 65 (19.6) 1.0 (0.8 to 1.2) 0.944 46 (13.9) 1.0 (0.8 to 1.2) 0.798
  ≥10 years of experience 453 (26.1) – – 244 (14.1) – –
  General practitioner 468 (25.4) 0.9 (0.5 to 1.5) 0.657 271 (14.7) 1.4 (0.8 to 2.4) 0.304
  Not general practitioner 53 (21.6) – – 20 (8.2) – –
Characteristics of the clinic
  Urban location 350 (28.3) 0.7 (0.4 to 1.2) 0.247 195 (15.8) 0.5 (0.2 to 0.9) 0.028
  Not urban location 170 (20.3) – – 96 (11.5) – –
  Large practice 212 (39.1) 2.5 (1.2 to 4.9) 0.008 144 (26.6) 1.9 (1.3 to 2.7) <0.001
  Medium practice 78 (18.1) 1.1 (0.5 to 2.5) 0.765 57 (13.2) 0.8 (0.4 to 1.3) 0.324
  Small practice 182 (22.6) 0.6 (0.3 to 1.2) 0.130 78 (9.7) 0.6 (0.4 to 0.9) 0.011
  Solo practice 47 (16.4) – – 12 (4.2) – –
  In-house colleague qualified in 
medical a specialty which traditionally 
uses ultrasonography†‡
90 (36.1) 2.1 (1.1 to 3.8) 0.016 99 (29.7) 3.0 (1.8 to 5.1) <0.001
n (%)=absolute number and percentage of dependent variable for each independent variable.
*ORs with 95% CI calculated using a mixed-effects logistic regression model including fixed effects for all variables and random-effects 
variables interacting with country.
†P values for adjusted OR
‡An in-house colleague who had specialised in internal medicine (for AbdUS) or gynaecology or obstetrics (for PelUS) was considered to 
have qualified in a medical specialty that traditionally uses ultrasonography.
AbdUS, access to in-house abdominal ultrasonography; PCP, primary care physician; PelUS, access to in-house pelvic ultrasonography.
may also be explained by the multidisciplinary nature 
of some larger clinics. Some countries, for example, 
Finland, Spain, Sweden and England, have multidisci-
plinary teams working in primary care, while others, 
for example, Switzerland, Romania, Norway, Germany, 
Denmark and Bulgaria, tend to have less staff.28 29 In our 
study, we found an association between in-house ultraso-
nography availability and having a colleague in the clinic 
who was qualified in a medical specialty which tradition-
ally uses ultrasonography. However, we do not know if 
these colleagues were performing ultrasonography exam-
inations, and most PCPs did not have such colleagues. 
As AbdUS and PelUS can be performed by PCPs with 
different educational backgrounds and correspondingly 
different levels of ultrasound training, quality assurance 
of ultrasound examinations performed in primary care 
is important.
Implications
Several factors may influence the availability of ultra-
sonography in primary care across Europe, including 
who performs the examinations and the organisation of 
healthcare systems. This study may generate hypotheses 
for future studies that further explore national factors. 
As ultrasonography is disseminating into primary care, 
knowledge about the influence that these factors have are 
important to guide the implementation process and to 
secure appropriate use of the technology.
COnCluSIOnS
PCPs’ access to in-house ultrasonography in primary care 
across Europe varied from 0% to 98% for AbdUS, and 
0% to 31% for PelUS. While in-house ultrasonography 
might be an important tool to ensure faster and more 
correct diagnosis in primary care, in every country except 
Germany it was available to less than half of our PCP 
respondents. As evidence continues to support point-of-
care ultrasonography as a front-line test, implementation 
strategies for the increased availability of the technology 
in primary care are needed. Several factors might influ-
ence PCPs’ access to in-house diagnostic ultrasonog-
raphy, and future research should focus on exploring 
these factors further.
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